The Role of Bone Morphogenetic Protein Receptor Type 2 (<i>BMPR2</i>) and the Prospects of Utilizing Induced Pluripotent Stem Cells (iPSCs) in Pulmonary Arterial Hypertension Disease Modeling

The Role of Bone Morphogenetic Protein Receptor Type 2 (<i>BMPR2</i>) and the Prospects of Utilizing Induced Pluripotent Stem Cells (iPSCs) in Pulmonary Arterial Hypertension Disease Modeling

Pulmonary arterial hypertension (PAH) is a progressive disease characterized by increased pulmonary vascular resistance (PVR), causing right ventricular hypertrophy and ultimately death from right heart failure. Heterozygous mutations in the bone morphogenetic protein receptor type 2 (<i>BMPR2...

Full description

Bibliographic Details
Main Authors:	Anichavezhi Devendran, Sumanta Kar, Rasheed Bailey, Maria Giovanna Trivieri
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	Cells
Subjects:	pulmonary arterial hypertension pulmonary vascular resistance vascular remodeling induced pluripotent stem cell disease modeling pulmonary arterial endothelial cells
Online Access:	https://www.mdpi.com/2073-4409/11/23/3823

Similar Items

Editorial: Pathophysiology and Pathogenic Mechanisms of Pulmonary Vascular Disease
by: Jinsheng Zhu, et al.
Published: (2022-03-01)

Generation of two induced pluripotent stem cell lines from patients suffering from pulmonary hypertension
by: Gaoxian Chen, et al.
Published: (2023-10-01)

Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat
by: Lin Huang, et al.
Published: (2022-06-01)

<i>Egln1<sup>Tie2Cre</sup></i> Mice Exhibit Similar Therapeutic Responses to Sildenafil, Ambrisentan, and Treprostinil as Pulmonary Arterial Hypertension (PAH) Patients, Supporting <i>Egln1<sup>Tie2Cre</sup></i> Mice as a Useful PAH Model
by: Yi Peng, et al.
Published: (2023-01-01)

Preventive treatment with ginsenoside Rb1 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats and involves store-operated calcium entry inhibition
by: Rui-Xing Wang, et al.
Published: (2020-01-01)

Abnormal Pulmonary Arterial Elastance Is Associated With Reduced Exercise Capacity in Tetralogy of Fallot
by: Alexander C. Egbe, et al.
Published: (2019-06-01)

Aloperine suppresses human pulmonary vascular smooth muscle cell proliferation via inhibiting inflammatory response
by: Zhi Chang, et al.
Published: (2019-01-01)

Echocardiographic evaluation of pulmonary hypertension
by: Rajesh Krishnachandra Shah
Published: (2018-01-01)

Andrographolide Attenuates Established Pulmonary Hypertension via Rescue of Vascular Remodeling
by: Xiaowei Nie, et al.
Published: (2021-11-01)

TNF-α and IL-8 levels are positively correlated with hypobaric hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats
by: Shi Haixia, et al.
Published: (2023-07-01)

The effect of transglutaminase-2 inhibitor on pulmonary vascular remodeling in rats with pulmonary arterial hypertension
by: Ting Wang, et al.
Published: (2022-02-01)

Sequential combination therapy with parenteral prostacyclin in BMPR2 mutations carriers
by: Athénaïs Boucly, et al.
Published: (2022-01-01)

Transcription factors and potential therapeutic targets for pulmonary hypertension
by: Liu Yang, et al.
Published: (2023-03-01)

Aortic Arch Anomalies and Pulmonary Artery Anomalies : Echocardiographic Evaluation
by: Prashant Mahawar
Published: (2020-01-01)

Effect of overexpression of microRNA-124 on pulmonary vascular remodeling in rats with pulmonary arterial hypertension
by: Zhu Jian, Chen Tiantian, Liu Zhiyong, Zheng Changlong
Published: (2023-08-01)

Mechanistic and therapeutic perspectives of baicalin and baicalein on pulmonary hypertension: A comprehensive review
by: Lidan Cui, et al.
Published: (2022-07-01)

Pulmonary Hypertension in Pregnancy: A Review
by: Humayun Anjum, et al.
Published: (2021-03-01)

Exercise metabolomics in pulmonary arterial hypertension: Where pulmonary vascular metabolism meets exercise physiology
by: Michael H. Lee, et al.
Published: (2022-09-01)

Extracellular vesicles derived from endothelial cells in hypoxia contribute to pulmonary artery smooth muscle cell proliferation in‐vitro and pulmonary hypertension in mice
by: Tianji Chen, et al.
Published: (2022-01-01)

Overexpression of Msx1 in Mouse Lung Leads to Loss of Pulmonary Vessels Following Vascular Hypoxic Injury
by: James West, et al.
Published: (2021-09-01)

Transpulmonary generation of cell‐free hemoglobin contributes to vascular dysfunction in pulmonary arterial hypertension via dysregulated clearance mechanisms
by: Jamie E. Meegan, et al.
Published: (2023-01-01)

Hemodynamic and Clinical Profiles of Pulmonary Arterial Hypertension Patients with GDF2 and BMPR2 Variants
by: Mei-Tzu Wang, et al.
Published: (2024-02-01)

Is iron deficiency caused by BMPR2 mutations or dysfunction in pulmonary arterial hypertension patients?
by: Vivienne Theobald, et al.
Published: (2023-04-01)

Galectin-3- Mediated Transdifferentiation of Pulmonary Artery Endothelial Cells Contributes to Hypoxic Pulmonary Vascular Remodeling
by: Li Zhang, et al.
Published: (2018-11-01)

Comprehensive assessments of pulmonary circulation in children with pulmonary hypertension associated with congenital heart disease
by: Jun Muneuchi, et al.
Published: (2022-10-01)

TGF-β1, pSmad-2/3, Smad-7, and β-Catenin Are Augmented in the Pulmonary Arteries from Patients with Idiopathic Pulmonary Fibrosis (IPF): Role in Driving Endothelial-to-Mesenchymal Transition (EndMT)
by: Archana Vijay Gaikwad, et al.
Published: (2024-02-01)

Characteristics of patients meeting the new definition of pre-capillary pulmonary hypertension (Nice 2018) in a single Japanese pulmonary hypertension center
by: Keiko Yamamoto, et al.
Published: (2021-08-01)

HIV and Schistosoma Co-Exposure Leads to Exacerbated Pulmonary Endothelial Remodeling and Dysfunction Associated with Altered Cytokine Landscape
by: Sandra Medrano-Garcia, et al.
Published: (2022-08-01)

Clinical features of pulmonary arterial hypertension associated with systemic sclerosis
by: Tijana Tuhy, et al.
Published: (2023-09-01)

Increased Methyl-CpG-Binding Domain Protein 2 Promotes Cigarette Smoke-Induced Pulmonary Hypertension
by: Jixing Wu, et al.
Published: (2022-06-01)

Quantification of Lung Perfusion Blood Volume in Dual-Energy Computed Tomography in Patients with Pulmonary Hypertension
by: Satoko Ugawa, et al.
Published: (2022-05-01)

Impact of Parenteral Prostanoids in Pulmonary Arterial Hypertension: The Relevance of Timing
by: Silvia Papa, et al.
Published: (2023-10-01)

Iatrogenic pulmonary artery perforation associated with 5-Fr catheter manipulation during pulmonary arteriovenous malformation embolization with a vascular plug
by: Jihoon Hong, MD, et al.
Published: (2022-03-01)

An adult with central cyanosis and differential pulmonary vascularity
by: Rajiv Ananthakrishna, et al.
Published: (2015-01-01)

Inactivating the Uninhibited: The Tale of Activins and Inhibins in Pulmonary Arterial Hypertension
by: Gusty Rizky Teguh Ryanto, et al.
Published: (2023-02-01)

Thoracic Vascular Variants and Anomalies: Imaging Findings, Review of the Embryology, and Clinical Features
by: Valentina Munera Orozco, et al.
Published: (2022-12-01)

Mechanisms of Hypoxia-Induced Pulmonary Arterial Stiffening in Mice Revealed by a Functional Genetics Assay of Structural, Functional, and Transcriptomic Data
by: Edward P. Manning, et al.
Published: (2021-09-01)

Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling
by: Liu J, et al.
Published: (2024-03-01)

iCPET Calculator: A Web‐Based Application to Standardize the Calculation of Alpha Distensibility in Patients With Pulmonary Arterial Hypertension
by: Jordan Elliott, et al.
Published: (2023-10-01)

Compound BMPR2 gene mutations in a malignant variant of idiopathic pulmonary arterial hypertension
by: Walter Serra, et al.
Published: (2014-12-01)